Assembly Biosciences Inc — Quarterly Cash Flow (NASDAQ:ASMB) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Total assets 100.26 M119.17 M99.02 M80.78 M240 M Total liabilities 74.26 M85.81 M71.88 M62.68 M57.3 M Total equity 26 M33.36 M27.13 M18.1 M182.69 M Total liabilities & shareholders' equities 100.26 M119.17 M99.02 M80.78 M240 M Total debt ————— Net debt —————

Nouvelles

Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Assembly Biosciences (NASDAQ:ASMB), Gilead Sciences (NASDAQ:GILD)

Gilead exercises option for Assembly Bio’s herpes treatment programs

Jefferies повышает целевую цену акций Assembly Biosciences до $62

Jefferies raises Assembly Biosciences stock price target to $62 on HSV data

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies - Slideshow (NASDAQ:ASMB) 2025-12-08

Акции Assembly Biosciences растут после успешных результатов препарата от ВПГ

Assembly Biosciences stock rises after promising HSV drug results

Assembly Bio сообщает о сильных результатах лечения ВПГ в испытаниях